These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
663 related items for PubMed ID: 21403587
1. Hepatic preconditioning using lipopolysaccharide: association with specific negative regulators of the Toll-like receptor 4 signaling pathway. Sano T, Izuishi K, Hossain MA, Inoue T, Kakinoki K, Hagiike M, Okano K, Masaki T, Suzuki Y. Transplantation; 2011 May 27; 91(10):1082-9. PubMed ID: 21403587 [Abstract] [Full Text] [Related]
2. Protective effect of lipopolysaccharide preconditioning in hepatic ischaemia reperfusion injury. Sano T, Izuishi K, Hossain MA, Kakinoki K, Okano K, Masaki T, Suzuki Y. HPB (Oxford); 2010 Oct 27; 12(8):538-45. PubMed ID: 20887321 [Abstract] [Full Text] [Related]
3. Lipopolysaccharide preconditioning protects hepatocytes from ischemia/reperfusion injury (IRI) through inhibiting ATF4-CHOP pathway in mice. Rao J, Qin J, Qian X, Lu L, Wang P, Wu Z, Zhai Y, Zhang F, Li G, Wang X. PLoS One; 2013 Oct 27; 8(6):e65568. PubMed ID: 23750267 [Abstract] [Full Text] [Related]
4. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation. Ajamieh H, Farrell G, Wong HJ, Yu J, Chu E, Chen J, Teoh N. J Gastroenterol Hepatol; 2012 Aug 27; 27(8):1353-61. PubMed ID: 22432744 [Abstract] [Full Text] [Related]
5. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway. Zhang S, Yang N, Ni S, Li W, Xu L, Dong P, Lu M. Int J Clin Exp Pathol; 2014 Aug 27; 7(10):6626-34. PubMed ID: 25400741 [Abstract] [Full Text] [Related]
6. Inhibiting the toll-like receptor 4 Toll/interleukin-1 receptor domain protects against hepatic warm ischemia and reperfusion injury in mice. Meimei H, Dejin M, Erzhen C, Minmin S, Songyao J, Jianfang L, Hao C. Crit Care Med; 2014 Feb 27; 42(2):e123-31. PubMed ID: 24231763 [Abstract] [Full Text] [Related]
7. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway. Wang H, Li ZY, Wu HS, Wang Y, Jiang CF, Zheng QC, Zhang JX. Chin Med J (Engl); 2007 Mar 20; 120(6):509-14. PubMed ID: 17439747 [Abstract] [Full Text] [Related]
8. Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: Toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity. Ke B, Shen XD, Tsuchihashi S, Gao F, Araujo JA, Busuttil RW, Ritter T, Kupiec-Weglinski JW. Hum Gene Ther; 2007 Apr 20; 18(4):355-66. PubMed ID: 17439357 [Abstract] [Full Text] [Related]
9. Plasma membrane-bound G protein-coupled bile acid receptor attenuates liver ischemia/reperfusion injury via the inhibition of toll-like receptor 4 signaling in mice. Yang H, Zhou H, Zhuang L, Auwerx J, Schoonjans K, Wang X, Feng C, Lu L. Liver Transpl; 2017 Jan 20; 23(1):63-74. PubMed ID: 27597295 [Abstract] [Full Text] [Related]
10. Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo. He D, Guo Z, Pu JL, Zheng DF, Wei XF, Liu R, Tang CY, Wu ZJ. Int Immunopharmacol; 2016 Jun 20; 35():201-209. PubMed ID: 27064547 [Abstract] [Full Text] [Related]
16. Asparagine attenuates hepatic injury caused by lipopolysaccharide in weaned piglets associated with modulation of Toll-like receptor 4 and nucleotide-binding oligomerisation domain protein signalling and their negative regulators. Wu H, Liu Y, Pi D, Leng W, Zhu H, Hou Y, Li S, Shi H, Wang X. Br J Nutr; 2015 Jul 07; 114(2):189-201. PubMed ID: 26079268 [Abstract] [Full Text] [Related]
17. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice. Kang JW, Kim DW, Choi JS, Kim YS, Lee SM. Food Chem Toxicol; 2013 Jul 07; 57():132-9. PubMed ID: 23535186 [Abstract] [Full Text] [Related]